A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
Completed
Bristol-Myers Squibb
Phase 3
2001-12-01
The purpose of this clinical research study is to see if Glucovance, a medication currently
approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and
effectively in children 9 to 16 years of age.
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
Completed
Bristol-Myers Squibb
Phase 4
2002-02-01
The purpose of this clinical research study is to support earlier observations that
Glucovance controls glucose levels after a mean, and improves overall glucose control better
than metformin or glyburide therapy alone in adults with type 2 diabetes.
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
Completed
Sanofi
Phase 3
2001-11-01
The purposes of the study is to determine whether blood sugar control is different between
Lantus and a third oral anti-diabetic agent when added to patients who fail a
thiazolidinedione and sulfonylurea or metformin combination.
Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients
Completed
GlaxoSmithKline
Phase 4
2003-05-01
The purpose of this study is to compare the vascular effects of two commonly used diabetes
medications, rosiglitazone and glyburide in type 2 diabetic patients.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
